Permanently Discontinued

APO-PHENYTOIN SODIUM

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-PHENYTOIN SODIUM discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-PHENYTOIN SODIUM 100MG has been permanently discontinued (last updated December 28, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-PHENYTOIN SODIUM not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength100MG

Last updated2018-12-28

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DILANTIN

BGP PHARMA ULC

100MG · DIN 00022780

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

NOVO-PHENYTOIN CAP 100MG

NOVOPHARM LIMITED

100MG · DIN 00037435

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TARO-PHENYTOIN

TARO PHARMACEUTICALS INC

100MG · DIN 02468255

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

DILANTIN INJ 50MG/ML

PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC.

250MG · DIN 00245453

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

PHENYTOIN SOIDUM INJECTION USP

PFIZER CANADA ULC

50MG · DIN 00497304

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

PHENYTOIN SODIUM INJECTION USP

SANDOZ CANADA INCORPORATED

50MG · DIN 00780626

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02460912

Strength

100MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

PHENYTOIN SODIUM

Tier

Unrated

Last Updated

2018-12-28

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-PHENYTOIN SODIUM has 2 shortage/discontinuation reports on file — this is one of them.

2026-06-22

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244